This topic contains a solution. Click here to go to the answer

Author Question: Regulation grants the authority to stop production of blood products in a blood manufacturing ... (Read 157 times)

bobbysung

  • Hero Member
  • *****
  • Posts: 519
Regulation grants the authority to stop production of blood products in a blood manufacturing organization when a problem is detected to which group of people?
 
  a. Executive members
  b. Leadership administrators
  c. Production managers
  d. Quality assurance unit

Question 2

Quality assurance is defined as
 
  a. conformance of a product or process with pre-established specifications
  b. documented evidence that provides a high degree of assurance that a specific process will consistently produce a product meeting predetermined specifications
  c. monitoring performed to ensure that the quality system is being adhered to and is effective
  d. standardization of an analytic instrument



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Tabitha_2016

  • Sr. Member
  • ****
  • Posts: 344
Answer to Question 1

Answer: d

Answer to Question 2

This is great. Thanks





 

Did you know?

Each year in the United States, there are approximately six million pregnancies. This means that at any one time, about 4% of women in the United States are pregnant.

Did you know?

A cataract is a clouding of the eyes' natural lens. As we age, some clouding of the lens may occur. The first sign of a cataract is usually blurry vision. Although glasses and other visual aids may at first help a person with cataracts, surgery may become inevitable. Cataract surgery is very successful in restoring vision, and it is the most frequently performed surgery in the United States.

Did you know?

Urine turns bright yellow if larger than normal amounts of certain substances are consumed; one of these substances is asparagus.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Since 1988, the CDC has reported a 99% reduction in bacterial meningitis caused by Haemophilus influenzae, due to the introduction of the vaccine against it.

For a complete list of videos, visit our video library